Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment

Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment

Objective: To assess the role of social risk factors on adherence to tyrosine kinase inhibitors (TKI) therapy in chronic myeloid leukemia (CML) patients. Methods: This is a retrospective study and eligible patients were adults with CML on TKI treatment. Cases of no adherence to treatment were confi...

Full description

Bibliographic Details
Main Authors: Okumura LM, Antunes VD, Aguiar KS, Farias T, Andrzejevski VM, Funke VM
Format: Article
Language:English
Published: Centro de Investigaciones y Publicaciones Farmaceuticas 2015-06-01
Series:Pharmacy Practice
Subjects:
Medication Adherence
Risk Factors
Leukemia Myeloid
Protein Kinase Inhibitors
Qualitative Research
Brazil
Online Access:http://www.pharmacypractice.org/journal/index.php/pp/article/view/559/389

Similar Items

Similar Items